A retrospective study on the effect of Chinese patent medicine combined with conventional treatment on the survival outcomes of 313 patients with stage II-III NSCLC

CONCLUSION: The medium and long-term use of CPM/HSOS was positively associated with higher survival rate in NSCLC patients. Patients with high-level preoperative FIB level and those without surgery might have a poor prognosis in the following years.PMID:38555532 | DOI:10.18632/aging.205697

Source: Aging - March 31, 2024 Category: Biomedical Science Authors: Kegang Jia Chenxu Zhang Fang Li Bin He Shenglong Xie Jun Du Gang Feng Source Type: research